ACOTEC SCIEN.H. DL-00001 Market Cap ($198.13 Million)
Market Cap & Net Worth: ACOTEC SCIEN.H. DL-00001 (7W3)
ACOTEC SCIEN.H. DL-00001 market cap. ACOTEC SCIEN.H. DL-00001 (F:7W3) has a market capitalization of $198.13 Million (€169.47 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #16404 globally and #1561 in its home market, demonstrating a -6.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ACOTEC SCIEN.H. DL-00001's stock price €0.55 by its total outstanding shares 313389171 (313.39 Million). Also see 7W3 cash flow metrics for how efficiently the company converts equity into cash flow.
ACOTEC SCIEN.H. DL-00001 Market Cap History (2021–2026)
ACOTEC SCIEN.H. DL-00001 market cap history from 2021 to 2026. Data shows change from $439.66 Million to $197.85 Million (-21.66% CAGR). Check 7W3 share price today for real-time trading data and today's change.
ACOTEC SCIEN.H. DL-00001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ACOTEC SCIEN.H. DL-00001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ACOTEC SCIEN.H. DL-00001 (7W3) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.81x
ACOTEC SCIEN.H. DL-00001's market cap is 0.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.40x
ACOTEC SCIEN.H. DL-00001's market cap is 4.40 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $439.66 Million | $303.81 Million | -$79.08 Million | 1.45x | N/A |
| 2022 | $732.77 Million | $395.55 Million | $70.14 Million | 1.85x | 10.45x |
| 2023 | $450.65 Million | $473.85 Million | $14.49 Million | 0.95x | 31.11x |
| 2024 | $265.63 Million | $533.99 Million | $52.28 Million | 0.50x | 5.08x |
| 2025 | $523.93 Million | $644.63 Million | $119.18 Million | 0.81x | 4.40x |
Competitor Companies of 7W3 by Market Capitalization
Companies near ACOTEC SCIEN.H. DL-00001 in the global market cap rankings as of November 4, 2026. Also see ACOTEC SCIEN.H. DL-00001 (7W3) total assets for a full breakdown of the balance sheet.
Key companies related to ACOTEC SCIEN.H. DL-00001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of ACOTEC SCIEN.H. DL-00001 (2021–2026)
Market capitalization of ACOTEC SCIEN.H. DL-00001 from 2021 to today. Between 2021 and today, ACOTEC SCIEN.H. DL-00001's market cap moved from $439.66 Million to $ 197.85 Million, with a yearly change of -21.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €197.85 Million | -62.24% |
| 2025 | €523.93 Million | +97.24% |
| 2024 | €265.63 Million | -41.06% |
| 2023 | €450.65 Million | -38.50% |
| 2022 | €732.77 Million | +66.67% |
| 2021 | €439.66 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of ACOTEC SCIEN.H. DL-00001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $198.13 Million USD |
| MoneyControl | $198.13 Million USD |
| MarketWatch | $198.13 Million USD |
| marketcap.company | $198.13 Million USD |
| Reuters | $198.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ACOTEC SCIEN.H. DL-00001
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with… Read more